Stevens-Johnson syndrome associated with abacavir therapy [5]

Clinical Infectious Diseases

Volumn 35, Issue 7, 2002, Pages 902-

  Bossi, Philippe ^a   Roujeau, Jean Claude ^a   Bricaire, François ^a   Caumes, Eric ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; LAMIVUDINE; NEVIRAPINE; PYRIMETHAMINE SULFADIAZINE; ZIDOVUDINE;

ADULT; CASE REPORT; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PRIORITY JOURNAL; RASH; RECURRENCE RISK; STEVENS JOHNSON SYNDROME;

EID: 0036788429     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/342571     Document Type: Letter

References (3)

1. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328:1670-4.
2. Fagot JP, Mockenhaupt M, Bouwesz-Bavinck JN, Naldi L, Viboud C, Roujeau JC. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001; 15:1843-8.
3. Hetherington S, McGuirk S, Powell G, et al. Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clin Ther 2001; 23:1603-14.